Identity

Decoquinate is an active therapeutic chemical synthetic medicine used within the poultry sector to target specific parasitic infections.

Overview

Decoquinate is a high-priority therapeutic synthetic anticoccidial used in the Indian poultry industry. As a quinolone-class coccidiostat, it is specifically indicated for the prevention and treatment of Coccidiosis, targeting Eimeria species. To ensure compliance with food safety and regulatory standards, its administration requires a statutory withdrawal period of 3 days. Due to its resistance profile, it is primarily limited to short-term shuttle programs or starter diets.

Structured Facts

Indications

Coccidiosis, Eimeria species (sporozoites and early trophozoites).

Mechanism of Action

Reversibly inhibits mitochondrial respiration in the sporozoite stage by acting at the cytochrome b-c1 complex site, preventing energy synthesis and halting development.

Dosage

27.2 g/ton in complete feed.

Administration Route

Feed.

Withdrawal Period

3 Days (India); 0 Days (US/FDA).

Contraindications

Not specified in sources (carryover limits apply to laying birds).

Adverse Effects

Continuous monotherapy rapidly selects for resistant populations.

Quantitative Data

• Dose: 27.2 g/ton
• Withdrawal: 3 Days

Relationships

• Target Diseases: Coccidiosis (Eimeria species).
• Resistance: Rapid emergence of resistance under continuous use; requires alternation with ionophore coccidiostats.